| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 9e-06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |